Modern Retina May and June 2025

How artificial intelligence could enhance clinical trials.

Research from the iMIND lab at Duke University.

Retinal imaging and the future of early Alzheimer diagnosis.

Recapping a recent conversation led by Dilsher S. Dhoot, MD.

Cell and gene therapies in development for unmet needs.

Patients are highly motivated to slow disease progression with GA drugs and healthy lifestyle.

Insights on injection technique and the future potential of SCS treatments.

Make the most of your practice and your retina conference participation.

Modern Retina’s recent Case-Based Roundtable focused on next-generation treatments for retinal disease that provide advanced care for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Looking at innovative tools and their applications in different disease states can help to think creatively about ways to benefit patients in retina care.

Investigators take an in-depth look at all aspects of the technology.

A mutation-agnostic gene therapy approach offers new possibilities for patients with advanced retinal disease.